| Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | # Peptides (by Search Engine): A2 Sequest HT (IgG 293) | # Peptides (by Search Engine): B2 Sequest HT (Sel1L 293) | # Peptides (by Search Engine): C2 Sequest HT (WT 293) | # Peptides (by Search Engine): D2 Sequest HT (HKO 293) | # PSMs (by Search Engine): A2 Sequest HT (IgG 293) | # PSMs (by Search Engine): B2 Sequest HT (Sel1L 293) | # PSMs (by Search Engine): C2 Sequest HT (WT 293) | # PSMs (by Search Engine): D2 Sequest HT (HKO 293) | Abundance: F1: Sample, IgG 293 | Abundance: F2: Sample, Sel1L 293 | Abundance: F3: Sample, WT 293 | Abundance: F4: Sample, HKO 293 | Abundances Count: F1: Sample, IgG 293 | Abundances Count: F2: Sample, Sel1L 293 | Abundances Count: F3: Sample, WT 293 | Abundances Count: F4: Sample, HKO 293 | Modifications | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Ensembl Gene ID | Gene Symbol | Chromosome | Reactome Pathways | KEGG Pathways | # Razor Peptides |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| High | P10321 | "HLA class I histocompatibility antigen, C alpha chain OS=Homo sapiens OX=9606 GN=HLA-C PE=1 SV=3" | 0 | 77.86 | 49 | 14 | 36 | 8 | 366 | 40.6 | 6.04 | 1 | 1 | 3 | 14 | 1 | 1 | 4 | 30 | 2209902.445 | 3560716.031 | 7812487.594 | 175427567.8 | 4 | 5 | 7 | 17 | regulation of biological process;response to stimulus;transport | cell surface;endoplasmic reticulum;Golgi;membrane | protein binding | "Pf00129, Pf07654" | 3107 | ENSG00000204525.16 | HLA-C | 6 | "Interferon alpha/beta signaling; ER-Phagosome pathway; Neutrophil degranulation; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; Endosomal/Vacuolar pathway; Interferon gamma signaling; Antigen Presentation: Folding, assembly and peptide loading of class I MHC" | Viral carcinogenesis; Endocytosis; Allograft rejection; Epstein-Barr virus infection; Type I diabetes mellitus; Cell adhesion molecules (CAMs); Natural killer cell mediated cytotoxicity; HTLV-I infection; Phagosome; Autoimmune thyroid disease; Herpes simplex infection; Viral myocarditis; Graft-versus-host disease; Antigen processing and presentation | 8 |